Amgen (AMGN) PT Raised to $310 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $465.45 -0.12%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 3
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 3
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Amgen (NASDAQ: AMGN) to $310.00 (from $300.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Amgen (AMGN) call put ratio 1 call to 1 put with a focus on November 505 calls into quarter results
- Amgen (AMGN) call put ratio 1 call to 1 put into quarter results
- Ethos Technologies (LIFE) PT Raised to $55 at Citizens on 'Very Strong' Q3 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
